Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection

被引:88
作者
Purohit, P
Dupont, S
Stevenson, M
Green, MR
机构
[1] Univ Massachusetts, Med Ctr, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA
[2] Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA
关键词
HIV; in vitro selection; matrix protein; RNA-protein interaction;
D O I
10.1017/S1355838201002023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human immunodeficiency virus type-1 matrix protein (HIV-1 MA) is a multifunctional structural protein synthesized as part of the Pr55 gag polyprotein, We have used in vitro genetic selection to identify an RNA consensus sequence that specifically interacts with MA (K-d = 5 x 10(-7) M), This 13-nt MA binding consensus sequence bears a high degree of homology (77%) to a region (nt 1433-1446) within the POL open reading frame of the HIV-1 genome (consensus sequence from 38 HIV-1 strains). Chemical interference experiments identified the nucleotides within the MA binding consensus sequence involved in direct contact with MA. We further demonstrate that this RNA-protein interaction is mediated through a stretch of basic amino acids within MA. Mutations that disrupt the interaction between MA and its RNA binding site within the HIV-1 genome resulted in a measurable decrease in viral replication.
引用
收藏
页码:576 / 584
页数:9
相关论文
共 45 条
[31]   CHEMICAL CLEVELAND MAPPING - A RAPID TECHNIQUE FOR CHARACTERIZATION OF CROSS-LINKED NUCLEIC-ACID - PROTEIN COMPLEXES [J].
MIRFAKHRAI, M ;
WEINER, AM .
NUCLEIC ACIDS RESEARCH, 1993, 21 (15) :3591-3592
[32]  
PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993
[33]   INTERACTIONS OF A SMALL RNA WITH ANTIBIOTIC AND RNA LIGANDS OF THE 30S SUBUNIT [J].
PUROHIT, P ;
STERN, S .
NATURE, 1994, 370 (6491) :659-662
[34]   IDENTIFICATION OF A BINDING-SITE FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NUCLEOCAPSID PROTEIN [J].
SAKAGUCHI, K ;
ZAMBRANO, N ;
BALDWIN, ET ;
SHAPIRO, BA ;
ERICKSON, JW ;
OMICHINSKI, JG ;
CLORE, GM ;
GRONENBORN, AM ;
APPELLA, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :5219-5223
[35]   HIGH-AFFINITY SSDNA INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS [J].
SCHNEIDER, DJ ;
FEIGON, J ;
HOSTOMSKY, Z ;
GOLD, L .
BIOCHEMISTRY, 1995, 34 (29) :9599-9610
[36]   DISTINCT BINDING SPECIFICITIES AND FUNCTIONS OF HIGHER EUKARYOTIC POLYPYRIMIDINE TRACT-BINDING PROTEINS [J].
SINGH, R ;
VALCARCEL, J ;
GREEN, MR .
SCIENCE, 1995, 268 (5214) :1173-1176
[37]  
SOUTH TL, 1990, BIOCHEM PHARMACOL, V40, P1213
[38]   RNA recognition by HIV-1 Tat and Rev [J].
Tan, RY ;
Brodsky, A ;
Williamson, JR ;
Frankel, AD .
SEMINARS IN VIROLOGY, 1997, 8 (03) :186-193
[39]   Arginine-binding RNAs resembling TAR identified by in vitro selection [J].
Tao, JS ;
Frankel, AD .
BIOCHEMISTRY, 1996, 35 (07) :2229-2238
[40]   RNA PSEUDOKNOTS THAT INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE [J].
TUERK, C ;
MACDOUGAL, S ;
GOLD, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) :6988-6992